Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overhydration Negatively Affects Quality of Life in Peritoneal Dialysis Patients: Evidence from a Prospective Observational Study.
Yoon HE, Kwon YJ, Song HC, Kim JK, Song YR, Shin SJ, Kim HW, Lee CH, Lee TW, Kim YO, Kim BS, Moon KH, Chang YK, Kim SS, Bang K, Cho JT, Yun SR, Na KR, Kim YW, Han BG, Chung JH, Lee KY, Jeong JH, Hwang EA, Kim YS; Quality of Life of Dialysis Patients (QOLD) Study Group. Yoon HE, et al. Among authors: han bg. Int J Med Sci. 2016 Aug 11;13(9):686-95. doi: 10.7150/ijms.16372. eCollection 2016. Int J Med Sci. 2016. PMID: 27647998 Free PMC article.
Coronary artery calcification in Korean patients with incident dialysis.
Bae E, Seong EY, Han BG, Kim DK, Lim CS, Kang SW, Park CW, Kim CD, Shin BC, Kim SG, Chung W, Park JY, Lee JY, Kim YS. Bae E, et al. Among authors: han bg. Hemodial Int. 2017 Jul;21(3):367-374. doi: 10.1111/hdi.12493. Epub 2016 Oct 5. Hemodial Int. 2017. PMID: 27709829
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
Yoon SA, Han BG, Kim SG, Han SY, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang YH, Shin SH, Cha DR. Yoon SA, et al. Among authors: han sy, han bg. Diabetes Obes Metab. 2017 Apr;19(4):590-598. doi: 10.1111/dom.12863. Epub 2017 Feb 17. Diabetes Obes Metab. 2017. PMID: 28019072 Clinical Trial.
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
Han SY, Yoon SA, Han BG, Kim SG, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang Y, Kim B, Shin S, Cha DR. Han SY, et al. Among authors: han bg. Diabetes Obes Metab. 2018 Feb;20(2):292-300. doi: 10.1111/dom.13059. Epub 2017 Sep 6. Diabetes Obes Metab. 2018. PMID: 28719008 Clinical Trial.
Does Routine Bioimpedance-Guided Fluid Management Provide Additional Benefit to Non-Anuric Peritoneal Dialysis Patients? Results from COMPASS Clinical Trial.
Oh KH, Baek SH, Joo KW, Kim DK, Kim YS, Kim S, Oh YK, Han BG, Chang JH, Chung W, Na KY; Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS) study. Oh KH, et al. Among authors: han bg. Perit Dial Int. 2018 Mar-Apr;38(2):131-138. doi: 10.3747/pdi.2016.00241. Epub 2018 Jan 31. Perit Dial Int. 2018. PMID: 29386302 Clinical Trial.
273 results